Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide-Reference-Cited by-同舟云学术

Glucagon-Like Peptide 1-Based Therapies for Type 2 Diabetes: A Focus on Exenatide

Published:2005-04-01 Issue:2 Volume:23 Page:56-62
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Dungan Kathleen,Buse John B.

Abstract

IN BRIEF Therapies based on the incretin hormone glucagon-like peptide 1 are novel treatment options for type 2 diabetes that act through a variety of complementary mechanisms. Exenatide, which will likely become the first application to reach the market, has shown promise in phase III trials in reducing hemoglobin A1c without causing significant hypoglycemia or weight gain.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/23/2/56/342150/0056.pdf

Reference65 articles.

1. Nielsen LL, Young AA, Parkes DG: Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regul Pept 117: 77-88,2004

2. Nauck MA,Niedereich-Holz U, Ettler R, Holst JJ, Orskov C, Ritzel R: Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 273: E981-E988,1997

3. Orskov C, Holst JJ, Nielsen OV: Effect of truncated glucagon-like peptide-1[proglucagon-(78-107)amide] on endocrine secretion from pig pancreas, antrum,and nonantral stomach. Endocrinology 123: 2009-2013,1988

4. Stoffers DA,Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM:Insulinotropic glucagon-like peptide-1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741-748, 2000

5. Zhou J, Wang X,Pineyro MA, Egan JM: Glucagon-like peptide-1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48:2358-2366, 1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on Diabetes Mellitus: An Insight into the Current Scenarios, the Challenges of Therapy, and Application of Traditional Drugs;Current Traditional Medicine;2024-06

2. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation;Kidney International;2024-01

3. Synthesis of N-Acetyllactosamine and N-Acetyllactosamine-Based Bioactives;Journal of Agricultural and Food Chemistry;2021-06-21

4. Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats;Stem Cells and Development;2021-05-04

5. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin;Life Sciences;2020-07